Sildenafil citrate by XOMA Royalty for Female Hypoactive Sexual Desire Disorder: Likelihood of Approval

Sildenafil citrate is under clinical development by XOMA Royalty and currently in Phase II for Female Hypoactive Sexual Desire Disorder.

Sep 10, 2024 - 04:00

Sildenafil citrate is under clinical development by XOMA Royalty and currently in Phase II for Female Hypoactive Sexual Desire Disorder.

Read the original article

Tags:

Previous Article

CMN-005 by CoImmune for Mantle Cell Lymphoma: Likelihood of Approval

GSK’s Asthma Drug Meets Primary Endpoint in Phase 3 Trial

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Abemaciclib by Eli Lilly and Co for Neuroblastoma: Like...

Oct 25, 2023

STAT+: Midwest health systems Fairview and Sanford call off $14 billion merger

STAT+: Midwest health systems Fairview and Sanford call...

Jul 28, 2023

Listen: Vertex’s polarizing data, Aduhelm’s adieu, & an...

Feb 1, 2024